Dr. Weeks grew up in North Carolina where he attended North Carolina State University and received a degree in Chemical Engineering. He then attended Duke University where he received his Doctorate of Medicine. He trained in the “Triple Board” Program at the University of Utah. He is trained in child & adolescent psychiatry, adult psychiatry and pediatrics. He is also boarded in clinical informatics. He obtained his MBA from the Haslam College of Business. He is actively involved in leadership of the Medical Group and engaged in many aspects of operation He is the Medical Director of the Medical Group Analytics team. He is the Associate Chief Medical Information Officer for University Health and has served as the Interim CMIO where he oversaw the University Enterprise Data Warehouse as well as the clinical operation of the EMR.

Clinically, his area of expertise is in Treatment Resistant Mood Disorders where he provides consultative services and neuromodulation treatments like electroconvulsive therapy and transcranial magnetic stimulation. He is very involved in process improvement and efficiency in the delivery of healthcare. A particular focus is in Patient Reported Outcomes.

Academically, he has published multiple abstracts and posters on aspects of Electroconvulsive Therapy (ECT) at national conferences. He often gives lectures on ECT & Transcranial Magnetic Stimulation (TMS) as well as pharmacologic approaches in treating mood disorders. He is co-Principal Investigator for several current research studies on the use of Isoflurane/Propofol anesthesia to treat depression, development of blood biomarkers to identify depression and the evaluation of the neuro-cognitive side effects of ECT treatment.